Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...

Novo Nordisk has announced that its experimental obesity drug, CagriSema, is showing side effects similar to existing GLP-1 drugs. The company expects the new drug to deliver a 25% weight loss. Novo ...

Novo Nordisk said the side effects in trials so far for its experimental obesity drug CagriSema were similar to its GLP-1 ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted ...

Novo Nordisk said sales of weight-loss injection Wegovy soared 42 percent in the first nine months of 2024 ...

HYDERABAD: Getting ‘in shape’ has been a long cherished dream of many across the world. A to Z diets, intermittent fasting, ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of ...

A mother claims she felt like she was going to die when she accidentally injected 'five times' the recommended dose of a skinny jab which was sent to her as a freebie by a brand to promote their meds ...

As demand for popular weight-loss drugs like Wegovy and Zepbound skyrockets, patients are taking dosage amounts into their ...

Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...

Hims weight loss plans start at $199 per month, but the true cost depends on your personalized ... FuturHealth’s emphasis on ...